June 2017

Litha Pharma is pleased to announce the launch of our NEW Moxypen® packaging.

Moxypen® capsules contain amoxycillin trihydrate equivalent to amoxycillin 250 mg or 500 mg. When dispensed as directed, each 5ml of reconstituted Moxypen® powder for fruit-flavoured suspension contains amoxycillin trihydrateequivalent to 125 mg or 250 mg amoxycillin. The powder contains 0,1 % m/v sodium benzoate B.P. as a preservative.Moxypen® is indicated for infections caused by susceptible, non-penicillinase-producing organisms including :

1. Respiratory tract infections (upper & lower): sinusitis, pharyngitis, epiglottis, acute and chronic bronchitis and acute typical pneumonia;2. Otitis media;3. Urinary tract infections;4. Uncomplicated gonococcal infections;5. Meningitis (sensitivity tests must be performed);6. Gastro intestinal infections including salmonella and typhoid;7. Uncomplicated gastro enteritis and enteric fever;8. Miscellaneous: Skin and soft tissue infections, bacteremia and adjunct in the treatment of sepsis caused by gram-negative bacteria.

ANNOUNCEMENT

S4 Moxypen® 250 mg capsules. Reg. No. M/20.1.2/293. Each capsule contains amoxycillin trihydrate equivalent to amoxycillin 250 mg. S4 Moxypen® 500 mg capsules. Reg. No. M/20.1.2/294. Each capsule contains amoxycillin trihydrate equivalent to amoxycillin 500 mg. S4 Moxypen® 125 mg/5 ml Powder for suspension. Reg. No. M/20.1.2/540. Each 5 ml of suspension contains amoxycillin trihydrate equivalent to 125 mg amoxycillin and 0,1 % m/v sodium benzoate as a preservative. S4 Moxypen® 250 mg/5 ml Powder for suspension. Reg. No. M/20.1.2/541. Each 5 ml of suspension contains amoxycillin trihydrate equivalent to 250 mg amoxycillin and 0,1 % m/v sodium benzoate as a preservative. For full prescribing information refer to the package insert approved by the medicines regulatory authority. Further information is available on request to the holder of registration. HCR: Litha Pharma (Pty) Ltd. Co. Reg. No. 1994/008717/07. 106 16th Rd, Midrand, 1686. www.lithahealthcare.co.za LP 2115 06/2017.

Schedule

4

4

4

4

4

4

Proprietary Name

Moxypen® 250

Moxypen® 250

Moxypen® 500

Moxypen® 500

Moxpen® 125 mg/5 ml

Moxpen® 250 mg/5 ml

Nappi Code

744689007

744689015

744697018

744697026

830291008

830305009

Pack Size

15

100

15

100

100 ml

100 ml

Bar Code

6006750002510

6006750002527

6006750002534

6006750002541

6006750002039

6006750002046

SEP (Excl. VAT)

R 6,95

R 46,14

R 12,68

R 84,60

R 10,45

R 13,49

SEP (Incl. VAT)

R 7,93

R 52, 60

R 14,46

R 96,44

R 11,91

R 15,38

NEW PACKAGING

NEWPACKAGING